Table 2.
Costs and outcomes per woman by trial arm
Cytological surveillance | Immediate treatment | Biopsy and recall | |
---|---|---|---|
Mean cost (£) by expenditure category: | |||
Smear tests | 101.9 | 68.7 | 71.5 |
Colposcopy without treatment | 30.7 | 87.7 | 149.5 |
Colposcopy with treatment | 25.1 | 106.3 | 40.7 |
Hospital visits | 7.3 | 6.8 | 8.5 |
Complications | 1.5 | 2.5 | 2.5 |
Time and travel (non-NHS) | 59.1 | 107.1 | 94.2 |
NHS costs (£): | |||
Mean | 166.5 | 272.1 | 272.4 |
Median | 89.5 | 231.4 | 220.7 |
IQR | 89.5-148.2 | 172.7-313.5 | 172.6-319.5 |
Mean, discounted | 150.2 | 240.3 | 241.1 |
Skew coefficient | 2.80 | 3.64 | 2.88 |
Social costs (£): | |||
Mean | 225.6 | 379.1 | 366.6 |
Median | 130.6 | 343.5 | 305.9 |
IQR | 130.6-209.4 | 264.7-428.0 | 247.7-424.7 |
Mean, discounted | 204.4 | 339.9 | 327.5 |
Skew coefficient | 2.62 | 3.37 | 2.77 |
Outcomes (QALYs): | |||
Mean | 2.225 | 2.243 | 2.277 |
Median | 2.348 | 2.348 | 2.383 |
IQR | 2.120-2.500 | 2.120-2.500 | 2.165-2.500 |
Mean, discounted | 2.129 | 2.149 | 2.181 |
Skew coefficient | −2.83 | −2.22 | −2.92 |
Mean discounted costs (£) per CIN case detected: | |||
NHS perspective | 1241 | 1073 | 1256 |
Social perspective | 1689 | 1517 | 1706 |
QALY=quality adjusted life year.